Canaccord Genuity Maintains Buy on Twist Bioscience, Raises Price Target to $120

Canaccord Genuity analyst Kyle Mikson maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $90 to $120.